Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.

Fujii T, Shimada K, Anai S, Fujimoto K, Konishi N.

Cancer Sci. 2013 Mar;104(3):321-7. doi: 10.1111/cas.12089. Epub 2013 Feb 14.

2.

ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.

Shimada K, Fujii T, Tsujikawa K, Anai S, Fujimoto K, Konishi N.

Clin Cancer Res. 2012 Oct 1;18(19):5247-55. doi: 10.1158/1078-0432.CCR-12-0955. Epub 2012 Jul 31.

3.

A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression.

Shimada K, Nakamura M, Anai S, De Velasco M, Tanaka M, Tsujikawa K, Ouji Y, Konishi N.

Cancer Res. 2009 Apr 1;69(7):3157-64. doi: 10.1158/0008-5472.CAN-08-3530. Epub 2009 Mar 17.

4.

The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.

Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R.

Neuro Oncol. 2013 Mar;15(3):269-78. doi: 10.1093/neuonc/nos301. Epub 2012 Dec 20.

5.

TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy.

Lee SY, Luk SK, Chuang CP, Yip SP, To SS, Yung YM.

Br J Cancer. 2010 Jul 27;103(3):362-9. doi: 10.1038/sj.bjc.6605797.

6.

Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.

Xiong D, Liou Y, Shu J, Li D, Zhang L, Chen J.

Exp Mol Pathol. 2014 Jun;96(3):411-21. doi: 10.1016/j.yexmp.2014.04.012. Epub 2014 Apr 24.

PMID:
24768914
7.

CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.

Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.

Urol Oncol. 2014 Aug;32(6):855-63. doi: 10.1016/j.urolonc.2014.01.005. Epub 2014 Jun 23.

PMID:
24968949
8.

Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.

Kaur S, Momi N, Chakraborty S, Wagner DG, Horn AJ, Lele SM, Theodorescu D, Batra SK.

PLoS One. 2014 Mar 26;9(3):e92742. doi: 10.1371/journal.pone.0092742. eCollection 2014.

9.

Frequent down-regulation of hABH2 in gastric cancer and its involvement in growth of cancer cells.

Gao W, Li L, Xu P, Fang J, Xiao S, Chen S.

J Gastroenterol Hepatol. 2011 Mar;26(3):577-84. doi: 10.1111/j.1440-1746.2010.06531.x.

PMID:
21155885
10.

Down-regulation of ALKBH2 increases cisplatin sensitivity in H1299 lung cancer cells.

Wu SS, Xu W, Liu S, Chen B, Wang XL, Wang Y, Liu SF, Wu JQ.

Acta Pharmacol Sin. 2011 Mar;32(3):393-8. doi: 10.1038/aps.2010.216. Epub 2011 Jan 31.

11.

ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer.

Tasaki M, Shimada K, Kimura H, Tsujikawa K, Konishi N.

Br J Cancer. 2011 Feb 15;104(4):700-6. doi: 10.1038/sj.bjc.6606012. Epub 2011 Feb 1.

12.

Alkbh2 protects against lethality and mutation in primary mouse embryonic fibroblasts.

Nay SL, Lee DH, Bates SE, O'Connor TR.

DNA Repair (Amst). 2012 May 1;11(5):502-10. doi: 10.1016/j.dnarep.2012.02.005. Epub 2012 Mar 17.

13.

Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1).

Patriarca C, Colombo P, Pio Taronna A, Wesseling J, Franchi G, Guddo F, Naspro R, Macchi RM, Giunta P, Di Pasquale M, Parente M, Arizzi C, Roncalli M, Campo B.

Int J Surg Pathol. 2009 Apr;17(2):99-106. doi: 10.1177/1066896908326918. Epub 2008 Nov 19.

PMID:
19019843
14.

Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.

Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H, Farhat WA.

Mol Carcinog. 2016 May;55(5):537-51. doi: 10.1002/mc.22300. Epub 2015 Mar 1.

PMID:
25728352
15.

Direct repair of 3,N(4)-ethenocytosine by the human ALKBH2 dioxygenase is blocked by the AAG/MPG glycosylase.

Fu D, Samson LD.

DNA Repair (Amst). 2012 Jan 2;11(1):46-52. doi: 10.1016/j.dnarep.2011.10.004. Epub 2011 Nov 11.

16.

Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.

Jitao W, Jinchen H, Qingzuo L, Li C, Lei S, Jianming W, Zhenli G.

Andrologia. 2014 Dec;46(10):1128-33. doi: 10.1111/and.12203. Epub 2013 Dec 16.

PMID:
24329492
17.

Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.

Zhu Z, Zhu Z, Pang Z, Xing Y, Wan F, Lan D, Wang H.

Int J Oncol. 2013 Apr;42(4):1271-8. doi: 10.3892/ijo.2013.1807. Epub 2013 Feb 5.

PMID:
23403865
18.

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.

Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, Bajaj E, Shanmugam K, Lee YY, Hwang SI, Gendler SJ, Mukherjee P.

Oncogene. 2011 Mar 24;30(12):1449-59. doi: 10.1038/onc.2010.526. Epub 2010 Nov 22.

19.

α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.

Liu J, Cai M, Chen J, Liao Y, Mai S, Li Y, Huang X, Liu Y, Zhang J, Kung H, Zeng Y, Zhou F, Xie D.

Eur J Cancer. 2014 Mar;50(4):840-51. doi: 10.1016/j.ejca.2013.11.038. Epub 2014 Jan 2.

PMID:
24388773
20.

Duplex interrogation by a direct DNA repair protein in search of base damage.

Yi C, Chen B, Qi B, Zhang W, Jia G, Zhang L, Li CJ, Dinner AR, Yang CG, He C.

Nat Struct Mol Biol. 2012 Jun 3;19(7):671-6. doi: 10.1038/nsmb.2320.

Supplemental Content

Support Center